Market Research Logo

Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 202

Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 2023

“Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market.”
The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

“The home care settings segment is expected to grow at the highest CAGR during the forecast period.”
Based on facility of use, the pharmaceutical drug delivery market is segmented hospitals, ambulatory surgical centers (ASCs)/clinics, diagnostic centers, home care settings, and other facilities of use. The home care settings segment is expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to increasing use of various drug delivery devices such as injectables, nebulizers, and inhalers in home care settings.

“The conventional injection devices segment accounted for the largest share of the injectable drug delivery market in 2018.”
Based on type, the injectable drug delivery technology is segmented into conventional injection devices, self-injection devices, and other devices. In 2018, conventional injection devices accounted for the largest share of the injectable drug delivery technology market. The large share of this segment can primarily be attributed to factors such as the low cost of devices and manufacturing, large molecular size of biologics administered through injectables, and the widespread popularity of conventional devices.

“North America to dominate the market during the forecast period.”
In 2018, North America accounted for the largest share of the pharmaceutical drug delivery market. The large share of the North American market is due to factors such as the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; growth in biologics in the pharmaceuticals market; and the presence of a large number of prominent players in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (55%), Tier 2 (25%), and Tier 3 (20%)
• By Designation: C-level (43%), D-level (32%), and Others (25%)
• By Region: North America (38%), Europe (23%), Asia (29%), and RoW (10%)

List of Companies Profiled in the Report
• Johnson & Johnson, Inc. (US)
• F. Hoffman-La Roche (Switzerland)
• Merck & Co., Inc. (US)
• Bayer AG (Germany)
• Pfizer, Inc. (US)
• Novartis AG (Switzerland)
• 3M Company (US)
• Becton, Dickinson and Company (US)
• GlaxoSmithKline plc, (UK)
• Sanofi (France)
• Antares Pharma, Inc. (US).

Research Coverage:
This report provides a detailed picture of the global pharmaceutical drug delivery market. It aims at estimating the size and future growth potential of the market across different segments, such as route of administration, application, facility of use, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical drug delivery market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • DRUG DELIVERY TECHNOLOGY: MARKET OVERVIEW
    • DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018 VS. 2023 (USD BILLION)
    • DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2018–2023 (USD BILLION)
    • DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY APPLICATION AND REGION, 2018
    • DRUG DELIVERY TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
    • DRIVERS
      • RISING PREVALENCE OF CHRONIC DISEASES
      • GROWTH IN THE BIOLOGICS MARKET
        • Table INDICATIVE LIST OF BIOLOGICS APPROVED BY THE FDA (2017)
      • TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
    • RESTRAINTS
      • RISK OF NEEDLESTICK INJURIES
    • OPPORTUNITIES
      • SELF-ADMINISTRATION AND HOME CARE
      • RISING DEMAND FOR BIOSIMILARS
    • CHALLENGES
      • PRICING PRESSURE
  • DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION
    • INTRODUCTION
      • Table DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
    • ORAL DRUG DELIVERY
      • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • SOLID ORAL DRUGS
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY REGION, 2016–2023 (USD BILLION)
        • Table CAPSULES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table POWDERS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table PILLS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • LIQUID ORAL DRUGS
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY REGION, 2016–2023 (USD BILLION)
        • Table ORAL SYRUPS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table ORAL SOLUTIONS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • SEMI-SOLID ORAL DRUGS
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY REGION, 2014–2021 (USD BILLION)
        • Table ORAL GELS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table ORAL EMULSIONS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table ELIXIRS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • INJECTABLE DRUG DELIVERY
      • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • CONVENTIONAL INJECTION DEVICES
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY REGION, 2016–2023 (USD BILLION)
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY MATERIAL, 2016–2023 (USD BILLION)
        • Table GLASS SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table PLASTIC SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY PRODUCT, 2016–2023 (USD BILLION)
        • Table FILLABLE SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table PREFILLED SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY USABILITY, 2016–2023 (USD BILLION)
        • Table REUSABLE SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table DISPOSABLE SYRINGES MARKET, BY REGION, 2016–2023 (USD BILLION)
      • SELF-INJECTION DEVICES
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELF-INJECTION DEVICES, BY TYPE, 2016–2023 (USD BILLION)
        • Table INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELF-INJECTION DEVICES, BY REGION, 2016–2023 (USD BILLION)
        • Table NEEDLE-FREE INJECTORS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table AUTOINJECTORS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table COMMERCIALLY AVAILABLE KEY PEN INJECTORS
        • Table PEN INJECTORS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table WEARABLE INJECTORS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • OTHER INJECTOR DEVICES
        • Table OTHER INJECTOR DEVICES MARKET, BY REGION, 2016–2023 (USD BILLION)
    • TOPICAL DRUG DELIVERY
      • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • LIQUID FORMULATIONS
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY REGION, 2016–2023 (USD BILLION)
        • Table TOPICAL SOLUTIONS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table TOPICAL SUSPENSIONS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • SEMI-SOLID FORMULATIONS
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY REGION, 2016–2023 (USD BILLION)
        • Table TOPICAL CREAMS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table TOPICAL GELS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table TOPICAL OINTMENTS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table TOPICAL PASTES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table TOPICAL LOTIONS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • SOLID FORMULATIONS
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY REGION, 2016–2023 (USD MILLION)
        • Table TOPICAL SUPPOSITORIES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table TOPICAL POWDERS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • TRANSDERMAL PRODUCTS
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2016–2023 (USD BILLION)
        • Table TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, BY REGION, 2016–2023 (USD BILLION)
        • Table TRANSDERMAL PATCHES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table TRANSDERMAL GELS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • OCULAR DRUG DELIVERY
      • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • LIQUID FORMULATIONS
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY REGION, 2016–2023 (USD BILLION)
        • Table COMMERCIALLY AVAILABLE EYE DROPS
        • Table EYE DROPS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table LIQUID SPRAYS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • SEMI-SOLID FORMULATIONS
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY REGION, 2016–2023 (USD MILLION)
        • Table OCULAR GELS MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table EYE OINTMENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • OCULAR DEVICES
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY TYPE, 2016–2023 (USD MILLION)
        • Table OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY REGION, 2016–2023 (USD MILLION)
        • Table DRUG-COATED CONTACT LENSES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table OCULAR INSERTS MARKET, BY REGION, 2016–2023 (USD BILLION)
    • PULMONARY DRUG DELIVERY
      • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • METERED-DOSE INHALERS
        • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR METERED-DOSE INHALERS, BY REGION, 2016–2023 (USD BILLION)
      • DRY POWDER INHALERS
        • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR DRY POWDER INHALERS, BY REGION, 2016–2023 (USD BILLION)
      • NEBULIZERS
        • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY TYPE, 2016–2023 (USD BILLION)
        • Table PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY REGION, 2016–2023 (USD BILLION)
        • Table JET NEBULIZERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table ULTRASONIC NEBULIZERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table SOFT MIST NEBULIZERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NASAL DRUG DELIVERY
      • Table NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • NASAL DROPS
        • Table NASAL DROPS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • NASAL SPRAYS
        • Table NASAL SPRAYS MARKET, BY REGION, 2016–2023 (USD BILLION)
      • NASAL POWDERS
        • Table NASAL POWDERS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • NASAL GELS
        • Table NASAL GELS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • TRANSMUCOSAL DRUG DELIVERY
      • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • ORAL FORMULATIONS
        • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016–2023 (USD BILLION)
        • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY REGION, 2016–2023 (USD BILLION)
        • Table BUCCAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD BILLION)
        • Table SUBLINGUAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD BILLION)
      • OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGIES
        • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
        • Table TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY REGION, 2016–2023 (USD MILLION)
        • Table RECTAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table VAGINAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
    • IMPLANTABLE DRUG DELIVERY
      • Table IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • ACTIVE IMPLANTABLE DRUG DELIVERY
        • Table ACTIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
      • PASSIVE IMPLANTABLE DRUG DELIVERY
        • Table PASSIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD BILLION)
  • DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE
    • INTRODUCTION
      • Table DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
    • HOSPITALS
      • HOSPITALS WILL CONTINUE TO DOMINATE THE DRUG DELIVERY TECHNOLOGY MARKET DURING THE FORECAST PERIOD
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD BILLION)
    • AMBULATORY SURGERY CENTERS/CLINICS
      • INCREASING PREFERENCE FOR ASCS HAS RESULTED IN A SIGNIFICANT RISE IN DEMAND FOR DRUG DELIVERY TECHNOLOGIES
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2016–2023 (USD BILLION)
    • HOME CARE SETTINGS
      • HOME CARE SETTINGS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR HOME CARE SETTINGS, BY REGION, 2016–2023 (USD BILLION)
    • DIAGNOSTIC CENTERS
      • RISING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2016–2023 (USD BILLION)
    • OTHER FACILITIES OF USE
      • Table DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FACILITIES OF USE, BY REGION, 2016–2023 (USD BILLION)
  • DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION
    • INTRODUCTION
      • Table DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD BILLION)
    • INFECTIOUS DISEASES
      • HIGH BURDEN OF INFECTIOUS DISEASES ACROSS THE GLOBE TO DRIVE MARKET GROWTH
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016–2023 (USD BILLION)
    • CANCER
      • CANCER FORMS A KEY THERAPEUTIC APPLICATION SEGMENT FOR DRUG DELIVERY TECHNOLOGIES
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR CANCER, BY REGION, 2016–2023 (USD BILLION)
    • CARDIOVASCULAR DISEASES
      • INCREASING PREVALENCE OF CVDS IS DRIVING THE GROWTH OF THE DRUG DELIVERY TECHNOLOGY MARKET
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2016–2023 (USD BILLION)
    • DIABETES
      • EMERGENCE OF NEW TECHNOLOGIES IS SUPPORTING MARKET GROWTH
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR DIABETES, BY REGION, 2016–2023 (USD BILLION)
    • RESPIRATORY DISEASES
      • HIGH PREVALENCE OF ASTHMA & COPD TO DRIVE THE ADOPTION OF DRUG DELIVERY TECHNOLOGIES
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2016–2023 (USD BILLION)
    • CENTRAL NERVOUS SYSTEM DISORDERS
      • ORAL AND INJECTABLE DRUG DELIVERY IN THE TREATMENT OF CNS DISORDERS
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2016–2023 (USD BILLION)
    • AUTOIMMUNE DISEASES
      • AUTOIMMUNE DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2016–2023 (USD BILLION)
    • OTHER APPLICATIONS
      • OPHTHALMIC DISORDERS
      • ENDOCRINE DISORDERS
        • Table DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD BILLION)
  • DRUG DELIVERY TECHNOLOGY MARKET, BY REGION
    • INTRODUCTION
      • Table DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY MATERIAL, 2016– 2023 (USD BILLION)
      • Table NORTH AMERICA: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY PRODUCT, 2016– 2023 (USD BILLION)
      • Table NORTH AMERICA: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY USABILITY, 2016– 2023 (USD BILLION)
      • Table NORTH AMERICA: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELFINJECTION DEVICES, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD BILLION)
      • Table NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • US
        • Table US: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table US: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • CANADA
        • Table CANADA: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table CANADA: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
    • EUROPE
      • Table EUROPE: DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD BILLION)
      • Table EUROPE: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
      • Table EUROPE: ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY MATERIAL, 2016–2023 (USD BILLION)
      • Table EUROPE: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY PRODUCT, 2016–2023 (USD BILLION)
      • Table EUROPE: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY USABILITY, 2016–2023 (USD BILLION)
      • Table EUROPE: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELF-INJECTION DEVICES, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table EUROPE: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table EUROPE: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD BILLION)
      • Table EUROPE: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • GERMANY
        • Table GERMANY: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table GERMANY: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • FRANCE
        • Table FRANCE: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table FRANCE: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • UK
        • Table UK: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table UK: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • REST OF EUROPE
        • Table ROE: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table ROE: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
    • ASIA PACIFIC
      • Table APAC: DRUG DELIVERY TECHNOLOGY MARKET, BY COUNTRY, 2016-2023 (USD BILLION)
      • Table APAC: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
      • Table APAC: ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table APAC: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table APAC: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table APAC: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table APAC: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • Table APAC: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY MATERIAL, 2016–2023 (USD BILLION)
      • Table APAC: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY PRODUCT, 2016–2023 (USD BILLION)
      • Table APAC: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY USABILITY, 2016–2023 (USD BILLION)
      • Table APAC: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELF-INJECTION DEVICES, BY TYPE, 2016–2023 (USD BILLION)
      • Table APAC: OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table APAC: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table APAC: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table APAC: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY TYPE, 2016–2023 (USD MILLION)
      • Table APAC: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table APAC: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table APAC: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table APAC: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table APAC: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table APAC: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, 2016–2023 (USD MILLION)
      • Table APAC: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table APAC: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table APAC: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016–2023 (USD BILLION)
      • Table APAC: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table APAC: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD BILLION)
      • Table APAC: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY TYPE, 2016–2023 (USD MILLION)
      • Table APAC: DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD BILLION)
      • Table APAC: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • JAPAN
        • Table JAPAN: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table JAPAN: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • CHINA
        • Table CHINA: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table CHINA: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • INDIA
        • Table INDIA: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
        • Table INDIA: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION)
        • Table ROA: DRUG DELIVERY TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD BILLION)
    • REST OF THE WORLD
      • Table ROW: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD BILLION)
      • Table ROW: ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table ROW: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID DRUGS, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table ROW: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID DRUGS, BY DOSAGE FORM, 2016-2023 (USD BILLION)
      • Table ROW: ORAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID DRUGS, BY DOSAGE FORM, 2016-2023 (USD MILLION)
      • Table ROW: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY MATERIAL, 2016–2023 (USD BILLION)
      • Table ROW: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, BY PRODUCT, 2016–2023 (USD BILLION)
      • Table ROW: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR CONVENTIONAL DEVICES, 2016–2023 (USD BILLION)
      • Table ROW: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET FOR SELF-INJECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: OCULAR DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD BILLION)
      • Table ROW: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table ROW: OCULAR DRUG DELIVERY TECHNOLOGY MARKET FOR OCULAR DEVICES, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR LIQUID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SEMI-SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR SOLID FORMULATIONS, BY DOSAGE FORM, 2016–2023 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER FORMULATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET FOR NEBULIZERS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD BILLION)
      • Table ROW: DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE, 2016–2023 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET PLAYER RANKING, 2017
      • Table DRUG DELIVERY TECHNOLOGY MARKET PLAYER RANKING, 2017
    • COMPETITIVE SCENARIO
      • Table PRODUCT LAUNCHES AND APPROVALS, 2016–2018
      • Table COLLABORATIONS, AGREEMENTS, AND JOINT VENTURES, 2016–2018
      • Table ACQUISITIONS, 2015–2018
      • Table EXPANSIONS, 2015–2018
    • COMPETITIVE LEADERSHIP MAPPING (2017)
      • VENDOR INCLUSION CRITERIA
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
  • COMPANY PROFILE
    • JOHNSON & JOHNSON SERVICES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAYER AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ANTARES PHARMA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GLAXOSMITHKLINE PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • 3M
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MERCK & CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SANOFI
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report